Tirzepatide Weight Loss Review
Pallas Health Tirzepatide Reviews 2026: $179 First Month, Provider Care Included, Brand-Name Options
Pallas Health is one of the few programs that keeps FDA-approved Zepbound and Mounjaro on the table alongside a compounded option, with provider care included and pricing by medication rather than dose.
- $179 first month, about $299/mo ongoing
- FDA-approved Zepbound and Mounjaro also available
- Priced by medication, not by dose
- Provider care included · no membership fee
$179 first month · ~$299/mo ongoing
Compounded and FDA-approved routes · confirm plan pricing at checkout
By Dr. Elena R. · Medically informed editorial review
Updated August 2026 · Pricing last checked August 2026
- FDA-approved options available
- Provider care included
- Priced by medication, not dose
- No membership fee
Pallas Health is one of the few tirzepatide programs offering both FDA-approved Zepbound/Mounjaro and a compounded option through the same provider. Its compounded plan opens at $179/first month, then $897 per 12 weeks, with provider care and messaging included and no membership fee.
About Pallas Health's Tirzepatide Program
Pallas Health is a private-pay telehealth weight-loss platform that offers both FDA-approved Zepbound and Mounjaro and a compounded tirzepatide option. Provider care, check-ins, and messaging are included with no separate membership fee, and the compounded plan is priced by medication rather than by dose. Pallas Health is operated by Brentmoor, Inc.
Tirzepatide is a dual agonist — it acts on both the GIP and GLP-1 receptors, not GLP-1 alone, making it the higher-efficacy molecule in this category. Pallas Health's distinguishing feature is choice: patients weighing FDA-approved branded product against compounded can be assessed by the same US-licensed clinician. For the platform as a whole, see our full Pallas Health program review.
Pallas Health Tirzepatide at a Glance
| Program type | Private-pay online GLP-1 program, 100% remote |
|---|---|
| Molecule reviewed here | Tirzepatide, a dual GIP and GLP-1 receptor agonist |
| First month | $179 |
| Ongoing | $897 per 12 weeks (about $299/month average) |
| Pricing model | By medication, not by dose |
| Also available | FDA-approved Zepbound and Mounjaro |
| Included | Provider care, check-ins, and messaging — no membership fee |
| Insurance | Private pay only (no insurance) |
Pallas Health Tirzepatide Pricing
| First month | $179 |
|---|---|
| Ongoing | $897 per 12 weeks |
| Average monthly | About $299/month |
| Pricing model | By medication, not by dose — titrating up does not raise the price |
| Included | Provider care, check-ins, messaging; no membership fee |
Pallas Health's structure is built around bundled clinical support: the plan price covers the medication plus provider care, check-ins, and messaging, with no membership fee layered on top. Because pricing is set by medication rather than dose, reaching your maintenance dose does not increase the plan cost. For a broader look at the tirzepatide programs we cover, our best weight loss treatments for 2026 roundup lists the options in one place.
How the Pallas Health Tirzepatide Program Works
- 1.Complete the online intake
Answer questions on health history, weight history, and goals online. There is no in-person visit required.
- 2.A US-licensed clinician reviews your file
A US-licensed clinician determines eligibility and whether a branded or compounded tirzepatide option is appropriate for you. A prescription is not guaranteed, and results vary.
- 3.Choose branded or compounded
Pallas Health offers FDA-approved Zepbound and Mounjaro as well as a compounded option, so you and the clinician can select the route that fits your needs.
- 4.Ongoing provider care included
Provider care, check-ins, and messaging are included with no membership fee. Tirzepatide is self-administered once weekly, and the plan price does not rise as your dose is titrated up.
Tirzepatide: What the Evidence and the Rules Say
The clinical case for tirzepatide over semaglutide is the dual-agonist mechanism. The FDA approved tirzepatide (the active ingredient in Zepbound) for chronic weight management on the strength of the SURMOUNT trial program, in which adults on the highest dose lost roughly a fifth of their body weight alongside lifestyle changes. Pallas Health offers that FDA-approved product directly, which is one reason the dual-option model is worth understanding.
Compounded medications are a separate category. As the FDA explains, compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy, or quality before they reach patients. Pallas Health offers both FDA-approved and compounded medications; compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician.
Pallas Health Tirzepatide Pros and Cons
Pros
- Offers FDA-approved Zepbound and Mounjaro as well as a compounded option
- Priced by medication, not by dose — titrating up does not raise the plan price
- Provider care, check-ins, and messaging included with no membership fee
- $179 first month lowers the cost of getting started
- A US-licensed clinician determines the appropriate treatment
- Fully online, private-pay program
Cons
- Private pay only — no insurance is billed
- Ongoing cost averages about $299/month after the first month
- Compounded medications are not FDA-approved and are not generic versions of brand-name drugs
- Eligibility and treatment are determined by a clinician; a prescription is not guaranteed
- Results vary from patient to patient
Pallas Health's standout is offering branded and compounded routes together. If you specifically want a compounded-only tirzepatide program instead, we separately review Embody and Novi. Pallas Health suits the patient who wants a clinician to weigh the FDA-approved and compounded options in one place.
Who Pallas Health Tirzepatide Is For
Pallas Health tirzepatide suits the patient who wants the option of FDA-approved Zepbound or Mounjaro and a compounded route assessed together by a US-licensed clinician, with provider care and messaging included and no membership fee. If having the branded choice on the table matters to you, the dual-option model is a real differentiator.
It is the wrong fit if you need insurance billing, since Pallas Health is private pay only. If you would rather look at a dedicated compounded program, we also review Enhance MD, and for the wider category start with the weight loss treatment guide at ExploreTreatments.com.
How We Scored Pallas Health Tirzepatide
Our 8.4/10 is a weighted mean of six categories, scored in August 2026 using the same criteria we apply to every GLP-1 program. Where we could not verify a claim, the category is capped rather than given full marks.
How We Scored It
Clear first-month and 12-week pricing by medication; ongoing ~$299/mo is toward the higher end of the field.
Keeps FDA-approved Zepbound and Mounjaro available with clinician-determined treatment and included provider care.
Provider check-ins and messaging included with no membership fee.
Provider-care model and solid reviews; compounded route still lacks independent evidence.
100% online, private-pay, both brand-name and compounded routes.
Established platform; FDA-approved options strengthen its evidence footing.
The same weighted method is applied to every provider we score, so competitor ratings are comparable. See our full methodology.
Editorial Verdict
Our Editorial Take
Pallas Health's edge is optionality. Offering FDA-approved Zepbound and Mounjaro alongside a compounded route, pricing by medication rather than dose, and bundling provider care and messaging with no membership fee make it a flexible choice — especially for patients who want the branded product on the table. A $179 first month keeps the entry approachable.
The honest caveats are that it is private pay only and the ongoing cost averages about $299/month. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs, and eligibility is determined by a US-licensed clinician, with results varying. Understand which route you are choosing, and Pallas Health holds up as a strong dual-option program.
Worth it if you want branded and compounded options weighed together with care included. Look elsewhere if you need insurance billing.
Pallas Health Tirzepatide Alternatives
If you are still shortlisting, JoinFridays, Trimi and Novi run comparable compounded tirzepatide programs. Our reviews cover the dose schedule, the renewal price and what shipping adds in each case.
Recommended Providers
Our editorial team’s top picks for this category.
Pallas Health Tirzepatide: Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.